#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autologous haematopoietic stem cell transplant Non-Hodgkin's lymphoma refractory Neoplasm malignant Neuroendocrine cell hyperplasia of infancy Immunodeficiency congenital Neuroendocrine carcinoma Cytomegalovirus infection Ovarian epithelial cancer Narcolepsy Hepatic angiosarcoma Autoimmune myositis Desmoid tumour Paget's disease of the vulva Palmar-plantar erythrodysaesthesia syndrome Corneal neovascularisation More trials…

    Learn about Rare Diseases

    Ocular melanoma – Diagnostics Alexander disease – Trials in Disease Wiskott-Aldrich syndrome – Treatment Mantle cell lymphoma – Trials in Disease VEXAS syndrome – Basic Information Hyperoxaluria – Diagnostics Glycogen storage disease type II – Treatment Gaucher’s disease type III – Diagnostics Rosai-Dorfman syndrome – Diagnostics Tuberous sclerosis complex – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Misoprostol Oxymetazoline Hydrochloride Sodium Phosphate HRS 9531 Human Plasma Protein Spesolimab Masitinib R2R01 Agomelatine Bms-986408 Ladarixin Epirubicin Hydrochloride Lithium Carbonate Ziltivekimab Nelivaptan Dexamethasone Acetate Ph. Eur. Lorundrostat Immunglobulin Cedazuridine Ht-29-B More therapies…

    Learn about Your Condition

    Overweight Vascular calcification ROHHAD syndrome Retinopathy of prematurity Thyroid mass Mantle cell lymphoma recurrent Colitis Craniosynostosis Hyperplasia adrenal Primary amyloidosis Yellow fever Mucopolysaccharidosis III IgA nephropathy Hodgkin's disease Hypotransferrinaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Bezirkskrankenhaus St. Johann

Bezirkskrankenhaus St. Johann

Internal Medicine, Bahnhofstraße 14, St. Johann in Tirol, 6380, Austria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Icosapent Ethyl
    • Tiemonium Methylsulphate
    • Empagliflozin
    Austria Germany Poland

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!